1. United States Stocks

  2. •

    Health technology

  3. •

    Pharmaceuticals: major
PRAXSYN CORP

PRAXSYN CORP

OOTC:PXYN
0.00
USD
0.00
(0.00%)
0.01EPS
1.36P/E
10.78MMarket Cap
2005 Y
2006 Y
2007 Y
2008 Y
2009 Y
2010 Y
2011 Y
2012 Y
2013 Y
2014 Y
TTM
Revenue per Share
- -
- -
- -
- -
- -
0.04
0.04
- -
0.05
0.25
0.12
Basic EPS, GAAP
- -
- -
- -
- -
-0.08
-0.13
-0.18
-0.02
- -
-0.05
0.01
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
-0.07
-0.05
- -
-0.01
-0.09
-0.02
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
- -
- -
- -
- -
- -
0.01
-0.1
-0.04
-0.03
- -
0.01
Tangible Book Value per Share
- -
- -
- -
- -
- -
0.01
-0.1
-0.04
-0.03
- -
0.01
Basic Weighted Avg Shares
7
7
28
10
10
32
43
71
134
269
552
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
1
2
- -
7
67
63
Operating Margin (%)
- -
- -
-742.85
-33.94
- -
-281.85
-267.78
- -
45.78
39.14
32.55
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
- -
- -
- -
-1
-4
-8
-1
- -
-12
7
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
70.13
- -
43.42
Profit Margin (%)
- -
- -
-754.07
-33.94
- -
-300.77
-474.21
- -
3.29
-18.55
10.89
Working Capital
- -
- -
- -
- -
- -
- -
-1
-3
-6
-3
-17
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
- -
- -
- -
- -
- -
- -
-4
-3
-5
2
9
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
106.9
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
-163.08
- -
157.29
Return on Common Equity (%)
- -
-52.7
-269.14
-65.95
- -
- -
- -
- -
- -
- -
159.9

Capital Structure

USD

•

in mil. unless spec.
Mar'15
Jun'15
Sep'15
ST Debt
4
3
3
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
593
625
634
Market Capitalization
21
14
11

Working Capital

USD

•

in mil. unless spec.
Mar'15
Jun'15
Sep'15
Total Current Assets
15
14
13
Cash, Cash Equivalents & STI
2
5
1
Accounts Receivable, Net
12
7
11
Inventories
- -
1
1
Total Current Liabilities
16
20
29
Payables & Accruals
11
15
22
ST Debt
4
3
3
Deferred Revenue
- -
- -
- -

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-506.78%
-135.25%
Free Cash Flow
- -
2,391.98%
1,270.03%
Net Income, GAAP
- -
-1,036.55%
-5,470.05%
Sales/Revenue/Turnover
- -
- -
852.97%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2013
3
- -
- -
- -
7
2014
9
23
23
11
67
2015
14
18
20
- -
- -

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2013
- -
- -
- -
- -
- -
2014
-0.04
- -
- -
- -
-0.05
2015
- -
0.01
- -
- -
- -

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2013
- -
- -
- -
- -
- -
2014
- -
- -
- -
- -
- -
2015
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Sean Daly
Full Time Employees
66
Sector
Health technology
Industry
Pharmaceuticals: major
Address
7904 E CHAPARRAL RD STE A110-210 West Palm Beach AZ United States 85250
IPO Date
Sep 5, 2007
Website
praxsyn.com
Similar Companies
Eli Lilly and Company (NYSE:LLY)
Novo Nordisk A/S (NYSE:NVO)
Johnson & Johnson (NYSE:JNJ)
Pfizer, Inc. (NYSE:PFE)
Dr. Reddy's Laboratories Ltd. (NSE:DRREDDY)
Divi's Laboratories Limited (NSE:DIVISLAB)
Business
Praxsyn Corporation (PXYN), a healthcare company, provides medical practitioners with non-narcotic, non-habit-forming medications and related services for pain management, erectile dysfunction, and metabolic therapies. The company formulates therapeutic and preventative agents in transdermal creams, patches, and oral capsules; offers custom compounded topical pain medications marketed to industrial health physicians and medical clinics; and provides revenue cycle management solutions through its Praxsyn Capital Corporation (PraxCapita) subsidiary for healthcare providers focusing on personal injury claims. Through subsidiaries including Praxsyn Medical Inc. and Mesa Pharmacy Inc., it engages in retail pharmacy, medical supplies, equipment distribution, medical billing, prescriber services, and optimized delivery of pain management pharmaceuticals. Praxsyn operates primarily in the United States, serving patients under the California workers' compensation system and preferred provider contracts; it targets healthcare providers, industrial health sectors, and patients requiring compliant medical claims processing. Founded in 2005 and headquartered in Scottsdale, Arizona, with a listed address at 61 Spectrum Blvd, the company was formerly known as The PAWS Pet Company, Inc., before changing its name in March 2014. Recent leadership changes include the July 2023 resignation of CEO and sole board member Daniel Oswald, replaced by Sean Daly in the same roles across all subsidiaries.

Company News

Company News APIChatGPT

  • defenseworld.net

    Head-To-Head Review: Madrigal Pharmaceuticals (NASDAQ:MDGL) and Praxsyn (OTCMKTS:PXYN)